Dr. Keen-Hun Tai
Honorary
Clinical Pathology
80 Scholarly works
0 Projects
HIGHLIGHTS
2020
Journal article
Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial
DOI: 10.1016/j.ijrobp.2020.03.0142020
Journal article
Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial
DOI: 10.1016/j.radonc.2020.08.0102020
Journal article
Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial
DOI: 10.1016/j.ijrobp.2019.11.4152019
Journal article
The accuracy and precision of the KIM motion monitoring system used in the multi-institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trial
DOI: 10.1002/mp.13784]2019
Journal article
TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol
DOI: 10.1136/bmjopen-2019-0307312019
Conference Proceedings
Is MLC Tracking Or Gating a Better Real-Time Correction Strategy? An Analysis of the TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) Trial
2019
Conference Proceedings
Real-Time tracking improves treatment: The TROG Stereo Prostate Ablative Radiotherapy with KIM trial
DOI: 10.1016/S0167-8140(19)31262-9
RECENT SCHOLARLY WORKS
2019
Journal article
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial
DOI: 10.1016/S1470-2045(18)30757-52018
Conference Proceedings
Timing of Androgen Deprivation Therapy for Prostate Cancer Patients after Radiation: Planned Combined Analysis of Two Randomized Phase 3 Trials
DOI: 10.1016/j.ijrobp.2018.06.3582018
Journal article
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
DOI: 10.1016/j.eururo.2018.06.004